Literature DB >> 17948904

Perceptions of discrimination among persons who have undergone predictive testing for Huntington's disease.

Elizabeth Penziner1, Janet K Williams, Cheryl Erwin, Yvonne Bombard, Anne Wallis, Leigh J Beglinger, Michael R Hayden, Jane S Paulsen.   

Abstract

Potential discrimination from genetic testing may undermine technological advances for health care. Researching long-term consequences of testing for genetic conditions that may lead to discrimination is a public health priority. The consequences of genetic discrimination generate social, health, and economic burdens for society by diminishing opportunities for at-risk individuals in a range of contexts. The current study objective was to investigate perceptions of genetic stigmatization and discrimination among persons who completed predictive testing for Huntington's disease (HD). Using semi-structured interviews and computerized qualitative analysis, the perceptions of 15 presymptomatic persons with a positive gene test predicting HD were examined with regard to differential treatment following testing. The sample comprised 11 women and 4 men, mostly married (73%), aged between 22 and 62 years, with an average education of 14.6 years (SD +/- 2.57) and residing in urban, rural and suburban settings of eight U.S. States. Participants reported perceptions of consequences following disclosure of genetic test results in three areas: employment, insurance, and social relationships. Although most employed participants (90%) revealed their test results to their employers, nearly all reported they would not disclose this information to future employers. Most (87%) participants disclosed test results to their physician, but a similar majority (83%) did not tell their genetic status to insurers. Most participants (87%) disclosed test results to family and peers; patterns of disclosure varied widely. Discrimination concerns remain high in this sample and point to the need for more information to determine the extent and scope of the problem. Copyright 2007 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  2008        PMID: 17948904      PMCID: PMC3645880          DOI: 10.1002/ajmg.b.30600

Source DB:  PubMed          Journal:  Am J Med Genet B Neuropsychiatr Genet        ISSN: 1552-4841            Impact factor:   3.568


  37 in total

Review 1.  Genomic medicine--a primer.

Authors:  Alan E Guttmacher; Francis S Collins
Journal:  N Engl J Med       Date:  2002-11-07       Impact factor: 91.245

Review 2.  Population screening in the age of genomic medicine.

Authors:  Muin J Khoury; Linda L McCabe; Edward R B McCabe
Journal:  N Engl J Med       Date:  2003-01-02       Impact factor: 91.245

3.  A vision for the future of genomics research.

Authors:  Francis S Collins; Eric D Green; Alan E Guttmacher; Mark S Guyer
Journal:  Nature       Date:  2003-04-14       Impact factor: 49.962

4.  Genetic testing and Huntington's disease: issues of employment.

Authors:  Peter S Harper; Sjef Gevers; Guido de Wert; Susan Creighton; Yvonne Bombard; Michael R Hayden
Journal:  Lancet Neurol       Date:  2004-04       Impact factor: 44.182

5.  Major study commencing into genetic discrimination in Australia.

Authors:  Margaret F Otlowski; Sandra D Taylor; Kristine K Barlow-Stewart
Journal:  J Law Med       Date:  2002-08

6.  Reactions to predictive testing in Huntington disease: case reports of coping with a new genetic status.

Authors:  T B Wahlin; A Lundin; L Bäckman; E Almqvist; A Haegermark; B Winblad; M Anvret
Journal:  Am J Med Genet       Date:  1997-12-19

7.  Adults seeking presymptomatic gene testing for Huntington disease.

Authors:  J K Williams; D L Schutte; C A Evers; C Forcucci
Journal:  Image J Nurs Sch       Date:  1999

8.  Psychosocial impact of predictive testing for Huntington disease on support persons.

Authors:  J K Williams; D L Schutte; P A Holkup; C Evers; A Muilenburg
Journal:  Am J Med Genet       Date:  2000-06-12

9.  Predictive testing for Huntington disease in Canada: adverse effects and unexpected results in those receiving a decreased risk.

Authors:  M Huggins; M Bloch; S Wiggins; S Adam; O Suchowersky; M Trew; M Klimek; C R Greenberg; M Eleff; L P Thompson
Journal:  Am J Med Genet       Date:  1992-02-15

10.  Reluctance to undergo predictive testing: the case of Huntington disease.

Authors:  K A Quaid; M Morris
Journal:  Am J Med Genet       Date:  1993-01-01
View more
  26 in total

1.  Huntington disease: families' experiences of healthcare services.

Authors:  Heather Skirton; Janet K Williams; J Jackson Barnette; Jane S Paulsen
Journal:  J Adv Nurs       Date:  2010-03       Impact factor: 3.187

2.  Potential stigma associated with inclusion of the psychosis risk syndrome in the DSM-V: an empirical question.

Authors:  Lawrence H Yang; Ahtoy J Wonpat-Borja; Mark G Opler; Cheryl M Corcoran
Journal:  Schizophr Res       Date:  2010-04-18       Impact factor: 4.939

3.  Personal factors associated with reported benefits of Huntington disease family history or genetic testing.

Authors:  Janet K Williams; Cheryl Erwin; Andrew Juhl; James Mills; Bradley Brossman; Jane S Paulsen
Journal:  Genet Test Mol Biomarkers       Date:  2010-08-19

Review 4.  Global trends on fears and concerns of genetic discrimination: a systematic literature review.

Authors:  Annet Wauters; Ine Van Hoyweghen
Journal:  J Hum Genet       Date:  2016-01-07       Impact factor: 3.172

5.  Factors associated with experiences of genetic discrimination among individuals at risk for Huntington disease.

Authors:  Yvonne Bombard; JoAnne Palin; Jan M Friedman; Gerry Veenstra; Susan Creighton; Jane S Paulsen; Joan L Bottorff; Michael R Hayden
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-11-10       Impact factor: 3.568

6.  Civilian and military genetics: nondiscrimination policy in a post-GINA world.

Authors:  Susannah Baruch; Kathy Hudson
Journal:  Am J Hum Genet       Date:  2008-10       Impact factor: 11.025

7.  Early Detection of Huntington Disease.

Authors:  Jane S Paulsen
Journal:  Future Neurol       Date:  2010-01

8.  Consumer awareness and attitudes about insurance discrimination post enactment of the Genetic Information Nondiscrimination Act.

Authors:  Dawn C Allain; Sue Friedman; Leigha Senter
Journal:  Fam Cancer       Date:  2012-12       Impact factor: 2.375

9.  Media coverage of direct-to-consumer genetic testing.

Authors:  John Lynch; Ashley Parrott; Robert J Hopkin; Melanie Myers
Journal:  J Genet Couns       Date:  2011-06-03       Impact factor: 2.537

Review 10.  Ethical issues of predictive genetic testing for diabetes.

Authors:  Susanne B Haga
Journal:  J Diabetes Sci Technol       Date:  2009-07-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.